Physician profile
Mark H Edelman
NPI 1669483483
$6,925.74
in general payments reported to CMS, 2019-2025
27 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2020: $312 · 2021: $379 · 2022: $248 · 2023: $4,942 · 2024: $204 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,753 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,753.03 |
| Food and Beverage | $723.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $5,117.92 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medline Industries LP | $460.94 | 2019-2022 | |
| Smith+Nephew, INC. | $333.21 | 2019-2025 | Renasys Touch, Pico 7, Grafix Pl |
| Organogenesis INC. | $235.65 | 2019-2021 | |
| Kci USA, INC. | $144.06 | 2019-2020 | |
| Urgo Medical North America, LLC | $91.35 | 2022 | |
| Lilly USA, LLC | $48.95 | 2022-2025 | Mounjaro |
| Exact Sciences Corporation | $41.22 | 2025 | Cologuard Collection Kit |
| Medtronic, INC. | $36.86 | 2024 | V-Loc 180 |
| Endo Pharmaceuticals INC. | $33.88 | 2020-2021 | |
| Inspire Medical Systems, INC. | $30.17 | 2024 | Inspire |
| Mimedx Group, INC. | $30.11 | 2024 | |
| Tactile Systems Technology INC | $29.17 | 2019-2021 | |
| Astellas Pharma US INC | $28.41 | 2024 | Veozah |
| Misonix INC | $27.49 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $27.46 | 2025 | |
| Abiomed | $26.66 | 2025 | |
| Integra Lifesciences Corporation | $25.27 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $21.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.03 | 2024 | |
| Aroa Biosurgery Incorporated | $19.97 | 2022 | |
| Glaxosmithkline, LLC. | $17.68 | 2025 | Trelegy Ellipta |
| Novo Nordisk INC | $17.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.90 | 2022 | |
| Viatris Specialty LLC | $16.37 | 2025 | Yupelri |
| Checkpoint Surgical, INC | $14.41 | 2023 | Checkpoint Stimulators |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Edelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.